• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Viewing Cached Copyrighted Content Isn’t Infringing, UK Supreme Court Says

07/05/2013 by Intellectual Property Watch Leave a Comment

Internet users who merely read or view copyright-protected webpages enjoy a temporary copying exception under European Union and United Kingdom law and do not need permission from rights holders, the UK Supreme Court said in a 17 April ruling.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Europe, Human Rights, IP Law, Information and Communications Technology/ Broadcasting, Innovation/ R&D

IP-Watch Readers Save $200 On LES Spring Meeting, 14-16 May In Seattle

29/04/2013 by Intellectual Property Watch Leave a Comment

LES (USA & Canada) 2013 Spring Meeting
IP Matters In Every Deal
May 14-16 | Seattle, WA

Look Who’s Attending the 2013 LES Spring Meeting
The LES Spring Meeting, 14-16 May in Seattle, Washington, USA is your best opportunity to learn about the latest trends in licensing and network with the industry’s leading IP, licensing and business development dealmakers.    

CONNECT with your next partner, LEARN new strategies and practices, COLLABORATE with your colleagues during one of many networking sessions.

You don’t want to miss out!

IP Watch readers SAVE $200! Use code IPW13 when registering.

REGISTER!

DOWNLOAD THE BROCHURE!

View the full agenda here.


 

Join this Growing List of Participants:
(This is a partial list of confirmed attendees.)

Company Title
343 Industries IP Licensing Manager
Adobe VP, IP and Litigation
Allen Institute for Brain Science General Counsel
Aruze Gaming America Executive Vice President, General Counsel
Augme Technologies Director and CEO
Autodesk VP, Legal
Battelle/Pacific Northwest National Lab Commercialization Manager
Bayer MaterialScience LLC Manager IP/Library Information Services
Bill & Melinda Gates Foundation Associate General Counsel
Boeing IP Licensing Company Business Development
Boston University Licensing Director, Life Sciences
California Technology Ventures Founding Managing Director
Caterpillar Inc. Intellectual Asset Manager
Center for Infectious Diseases Executive VP of BD and External Affairs
Cryptography Research, Inc. Director
Eli Lilly and Company VP, Corporate Business Development
Fred Hutchinson Cancer Research Center VP, Industry Relations and Clinical Research Support
HealthPartners Institute IP Marketing and Licensing Manager
hipcricket Chief Executive Officer
HP VP & Associate General Counsel
HTC Sr. Director of Legal Affairs, IP Strategy
IBM Director of IP Strategy
Integrated Diagnostics Director of IP and Contracts
Intellectual Ventures VP, Acquisitions
Jet Propulsion Laboratory & Caltech Associate Director
John Deere Manager IP Market Transactions
Joint BioEnergy Institute Director of Commercialization
Juniper Networks Inc Assistant General Counsel
Lawrence Livermore National Laboratory Business Development Executive
Lehigh University Associate Director
Lexington Technology Group, Inc. CEO
LI-COR Biosciences VP Business Development and Intellectual Property
Merck Executive Director, Corporate Licensing
Microsoft Associate General Counsel
NeoMedia Technologies CEO
Nike Corporation VP, Chief IP Counsel
Northwest Energy Angels Board Member & Angel Investor
OncoSynergy Co-Founder
Oracle Patent Counsel
Oregon Health & Science University Interim Director
Pacific Northwest National Lab Director Technology Commercialization
PhaseBio Chief Business Officer
Purdue Research Foundation, OTC Senior Project Manager
Rockwell Collins, Inc. Senior Director, Intellectual Property Management 
Rutgers University Licensing Manager
SanDisk IP Counsel
Sanrio Vice Chairman
SAS Head of Corp Development & Planning
Schlumberger Manager of IP Licensing
Seattle Genetics Chief Operating Officer
Stanford University Senior Associate
Tech Bridge International, Inc. VP & Director of Operations
Textron Inc. Intellectual Property Director
The Boston Consulting Group Senior Advisor
The University of North Carolina at Charlotte Executive Director
The University of Oklahoma Senior Director of IP & Staff Attorney
T-Mobile Senior Vice President, National Accounts
Tuxera CEO
UCSF QB3 Institute Director Industrial Alliances
Univalor, L.P. Manager, Project and Technology Portfolio
University Health Network Senior Technology and Patent Analyst
University of Arizona Office of Tech Transfer Licensing Associate
University of California – Berkeley Licensing Officer
UW Center for Commercialization Associate Director, Technology Licensing – Engineering
Ventures West Capital General Partner
Washington Research Foundation Director of Licensing
WBBA President
Weyerhaeuser Director, Technology Licensing
WMS Gaming Executive Director IP Licensing and Development


Don’t Miss these Featured Sessions:

  • Hello Kitty as a Global Licensing & Marketing Phenomenon
  • Solving the World’s Imminent Problems with Innovative Science
  • Secondary Patent Market – Trends and Practices
  • IP Perspectives from a Northwest Angel Investor
  • West Coast Software Giants Focus on IP
  • Life Sciences: A Guide to Turning a Strategic Partnership into an Acquisition

View the full agenda here.

Filed Under: IP-Watch Briefs, IP Policies, Themes, Venues, Copyright Policy, English, IP Law, Information and Communications Technology/ Broadcasting, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains

US Supreme Court May Invalidate Gene Patents, But Create Little Change

23/04/2013 by Steven Seidenberg for Intellectual Property Watch Leave a Comment

Prior to 15 April, most experts had expected the United States Supreme Court to rule in Association for Molecular Pathology v. Myriad Genetics that genes cannot be patented. The oral argument on that date strengthened this consensus opinion, but also suggested that the court would issue a narrow decision which would allow many types of gene-related patents. Should this happen, the US would move significantly closer to other countries’ rules for gene patents, but the US would continue to have problems limiting patent rights in order to protect the public interest.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Access to Knowledge/ Education, Biodiversity/Genetic Resources/Biotech, English, Health & IP, Human Rights, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Perspectives on the US

The Novartis Decision: A Tale Of Developing Countries, IP, And The Role Of The Judiciary

15/04/2013 by Intellectual Property Watch 2 Comments

Ahmed Abdel Latif says of the Novartis case: The ruling is also a revealing tale about the changing role of developing countries in the global intellectual property landscape and the growing influence of the judiciary in these countries in the implementation of international intellectual property rules.

Filed Under: Inside Views, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Asia/Pacific, Biodiversity/Genetic Resources/Biotech, Development, English, Health & IP, IP Law, Patents/Designs/Trade Secrets, WTO/TRIPS

EU General Court Clears Copyright Collecting Societies Of Antitrust Charges

12/04/2013 by Dugie Standeford for Intellectual Property Watch Leave a Comment

European copyright collecting societies are not engaged in a cartel but the European Commission was correct in finding that some of the provisions in their reciprocal representation should be barred, the EU General Court (GC) said in a 12 April ruling. The case, which pits the International Confederation of Societies and Authors (CISAC) and 24 of its members against the EC, could be appealed to the EU Court of Justice (ECJ). CISAC said the decision proves its contention that it was not engaged in a conspiracy to restrict competition, and that it has already done away with the complained-of clauses.

Separately, the ECJ has been asked to tackle several key issues in a German matter involving standards-essential patents encumbered with a fair, reasonable and non-discriminatory (FRAND) licensing agreement.

Filed Under: IP Policies, Language, News, Subscribers, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Europe, Human Rights, IP Law

Community Right To Access Unpublished Works Trumps Moral Rights Of Heir, Argentine Court Says

11/04/2013 by Maximiliano Marzetti for Intellectual Property Watch 1 Comment

In a recent decision, Ediciones de la Flor SA c. Fontanarrosa Franco s. Acción Mere Declarativa (File No. 1420/08), the Court of First Instance in Civil and Commercial Matters No. 12 of Rosario, the second largest city in Argentina, ruled that the rights of the community to access unpublished works of a deceased author are superior to the moral rights of one of his heirs to oppose such publication.

Filed Under: Features, IP Policies, Language, Themes, Access to Knowledge/ Education, Copyright Policy, English, Human Rights, IP Law, Innovation/ R&D, Latin America/Caribbean

The Judgment In Novartis v. India: What The Supreme Court Of India Said

04/04/2013 by Intellectual Property Watch 9 Comments

Following the Indian Supreme Court decision in Novartis AG v. Union of India, Prof. Frederick Abbott says, “the judgment is well-crafted, with close attention to the facts presented, and appears to take a balanced view of the matters brought before the Court.”

Filed Under: Inside Views, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Asia/Pacific, Biodiversity/Genetic Resources/Biotech, Development, English, Health & IP, IP Law, Innovation/ R&D, Patents/Designs/Trade Secrets, WTO/TRIPS

Novartis Loses Patent Bid: Lessons From India’s 3(d) Experience

01/04/2013 by Patralekha Chatterjee for Intellectual Property Watch 15 Comments

New Delhi – On 1 April, in a packed room in India’s Supreme Court, two judges – Justice Aftab Alam and Justice Ranjana Desai – delivered a verdict that has the potential to dramatically change the national and global conversation about patents and patients.

Filed Under: Features, IP Policies, Language, Themes, Access to Knowledge/ Education, Asia/Pacific, Biodiversity/Genetic Resources/Biotech, Development, English, Europe, Health & IP, Human Rights, IP Law, Innovation/ R&D, Patents/Designs/Trade Secrets

US Court Rules TV Streaming Service Does Not Violate Copyright Law

01/04/2013 by Intellectual Property Watch Leave a Comment

The Second United States Circuit Court of Appeals today determined that online live television broadcasting service Aereo doesn’t violate US copyright law, upholding a lower court ruling. Aereo is a cloud computing-based service in New York City.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, IP Law, Information and Communications Technology/ Broadcasting, North America, Technical Cooperation/ Technology Transfer

India Dismisses Antitrust Complaint Against Gilead Sciences

01/04/2013 by Intellectual Property Watch Leave a Comment

The Indian fair trade regulator has dismissed a complaint against biopharmaceutical company Gilead Sciences that alleged the company engaged in anti-competitive activities in the licensing of its anti-HIV drugs, according to the SpicyIP blog.

Filed Under: IP-Watch Briefs, IP Policies, Themes, Asia/Pacific, Biodiversity/Genetic Resources/Biotech, English, Health & IP, IP Law, Patents/Designs/Trade Secrets

  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 74
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2026 · Global Policy Reporting